You are here: Industry Insights > Diabetes

News List

Health bodies test digital interventions for diabetes pharmatimes
November 16, 2017
NHS England, Public Health England and Diabetes UK have teamed up with leading companies from the tech sector to test new digital approaches to fighting type II diabetes.
Psoriasis patients at greater risk of type 2 diabetes, study reveals pharmafile
November 16, 2017
Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk of developing type 2 diabetes, with more severe forms of the condition being linked to greater risk.
Harnessing immunotherapy to reverse Type 1 diabetes fiercebiotech
November 16, 2017
In patients with Type 1 diabetes, T cells in the immune system mistakenly attack islet cells in the pancreas that make insulin
Eli Lilly announces an investment of US$72 million in core business pharmaasia
November 01, 2017
The company has a nine decade legacy of researching and producing the drug.
New injectable Bydureon BCise for type-2 diabetes patients approved by FDA pharmaasia
October 31, 2017
New Bydureon formulation of once-weekly exenatide in an improved device provides significant HbA1c reduction with added benefit of weight loss.
Smart artificial beta cells could lead to new diabetes treatment europeanpharmaceuticalreview
October 31, 2017
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar…
US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes biospectrumasia
October 24, 2017
It is an improved device provides significant HbA1c reduction with added benefit of weight loss
Novo's diabetes treatment semaglutide gets unanimous FDA backing pharmafile
October 20, 2017
Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one of the regulators advisory panels voting unanimously in favour of the drug’s approval.
AstraZeneca Pharma gets DCG(I) nod to market diabetes drug expressbpd
October 19, 2017
AstraZeneca Pharma has received marketing authorisation from the Drug Controller General India DCG(I) for Xigduo XR tablets used in treatment of adults with type II diabetes in India.
Sanofi plans summit to tackle diabetes in 5 million Nigerian citizens pharmafile
October 18, 2017
Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million of the nation’s citizens currently live with the condition.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page